Echocardiographic predictors of cardiovascular outcome in heart failure with preserved ejection fraction

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Nelson Wang

The George Institute for Global Health, Sydney (Australia)

5 More presentations in this session

Presentation thumbnail

The added value of cardiopulmonary exercise testing in the diagnosis of heart failure with preserved ejection fraction

Doctor L. Massa (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Chronotropic incompetence as a critical predictor for cardiovascular outcomes in heart failure with preserved ejection function

Doctor T. Lin (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Clinical correlates and prognostic impact of cognitive decline in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF

Doctor L. Shen (Glasgow, CN)

Abstract Slides Video

Presentation thumbnail

Exosome-like nanovesicle targeting visceral adipose tissue inflammation mitigates heart failure with preserved ejection fraction

Mrs Y. Jiang (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Effect and mechanism of Adipokine Omentin-1 on cardiac hypertrophy in heart failure with preserved ejection fraction

Doctor Q. Li (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Delving deeper into HFpEF

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources